尘螨皮下免疫治疗应用于儿童过敏性哮喘疗效OA北大核心CSTPCDMEDLINE
Efficacy and safety of dust mite subcutaneous immunotherapy in children with allergic asthma:a prospective randomized controlled study
目的 探讨尘螨皮下免疫治疗(subcutaneous immunotherapy,SCIT)应用于儿童过敏性哮喘的疗效和安全性.方法 采用前瞻性随机对照研究,将98例尘螨过敏哮喘患儿按随机数字表法分为对照组和SCIT组,每组49例.对照组吸入激素治疗;SCIT组除吸入激素治疗外,加用3年标准化SCIT.比较两组治疗前、治疗后6个月、治疗后1年、治疗后2年、治疗后3年外周血嗜酸性粒细胞百分比、视觉模拟评分、总用药评分、哮喘控制测试评分/儿童哮喘控制…查看全部>>
Objective To investigate the efficacy and safety of subcutaneous immunotherapy(SCIT)using dust mites in children with allergic asthma.Methods In a prospective randomized controlled study,98 children with dust mite-induced allergic asthma were randomly divided into a control group(n=49)and an SCIT group(n=49).The control group received inhaled corticosteroid treatment,while the SCIT group additionally received a standardized three-year SCIT regimen.The two gr…查看全部>>
王雅妮;鲁思琪;陈海;李玉勤;卢红艳;朱慧;常明
江苏大学附属医院儿科,江苏镇江 212001江苏大学附属医院儿科,江苏镇江 212001江苏大学附属医院儿科,江苏镇江 212001江苏大学附属医院儿科,江苏镇江 212001江苏大学附属医院儿科,江苏镇江 212001江苏大学附属医院儿科,江苏镇江 212001江苏大学附属医院儿科,江苏镇江 212001
皮下免疫治疗过敏性哮喘疗效安全性儿童
Subcutaneous immunotherapyAllergic asthmaEfficacySafetyChild
《中国当代儿科杂志》 2024 (6)
559-566,8
江苏省卫生健康委2022年度医学科研立项项目(M2022043)江苏省镇江市2023年度科技创新资金项目(SS2023012).
评论